Literature DB >> 1657665

Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes.

M F Vincent1, P J Marangos, H E Gruber, G Van den Berghe.   

Abstract

5-Amino-4-imidazolecarboxamide (AICA) riboside, the nucleoside corresponding to AICA ribotide (AICAR or ZMP), an intermediate of the de novo pathway of purine biosynthesis, was found to exert a dose-dependent inhibition on gluconeogenesis in isolated rat hepatocytes. Production of glucose from lactate-pyruvate mixtures was half-maximally inhibited by approximately 100 microM and completely suppressed by 500 microM AICA riboside. AICA riboside also inhibited the production of glucose from all other gluconeogenic precursors investigated, i.e., fructose, dihydroxyacetone, and L-proline. Measurements of intermediates of the glycolytic-gluconeogenic pathway showed that AICA riboside provoked elevations of triose phosphates and fructose-1,6-bisphosphate and decreases in fructose-6-phosphate and glucose-6-phosphate. The effects of AICA riboside persisted when the cells were washed 10 min after its addition but were suppressed by 5-iodotubercidin, an inhibitor of adenosine kinase. AICA riboside provoked a dose-dependent buildup of normally undetectable Z nucleotides. After 20 min of incubation with 500 microM AICA riboside, ZMP, ZTP, and ZDP reached 3, 0.3, and 0.1 mumol/g cells, respectively. Concentrations of ATP were not significantly modified by addition of up to 500 microM AICA riboside when the cells were incubated with lactate-pyruvate but decreased with fructose or dihydroxyacetone. The activity of rat liver fructose-1,6-bisphosphatase was inhibited by ZMP with an apparent Ki of 370 microM. It is concluded that AICA riboside exerts a suppressive effect on gluconeogenesis because it provokes an accumulation of ZMP, which inhibits fructose-1,6-bisphosphatase.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657665     DOI: 10.2337/diab.40.10.1259

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  61 in total

Review 1.  Metabolic enzymes as targets for 14-3-3 proteins.

Authors:  Steven C Huber; Carol MacKintosh; Werner M Kaiser
Journal:  Plant Mol Biol       Date:  2002-12       Impact factor: 4.076

Review 2.  Folate-Dependent Purine Nucleotide Biosynthesis in Humans.

Authors:  Joseph E Baggott; Tsunenobu Tamura
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

Review 3.  AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels.

Authors:  D Grahame Hardie
Journal:  Annu Rev Nutr       Date:  2014-05-15       Impact factor: 11.848

Review 4.  Beyond AICA riboside: in search of new specific AMP-activated protein kinase activators.

Authors:  Bruno Guigas; Kei Sakamoto; Nellie Taleux; Sara M Reyna; Nicolas Musi; Benoit Viollet; Louis Hue
Journal:  IUBMB Life       Date:  2009-01       Impact factor: 3.885

5.  Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function.

Authors:  Julian M W Quinn; Shanna Tam; Natalie A Sims; Hasnawati Saleh; Narelle E McGregor; Ingrid J Poulton; John W Scott; Matthew T Gillespie; Bruce E Kemp; B J W van Denderen
Journal:  FASEB J       Date:  2009-09-01       Impact factor: 5.191

6.  5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.

Authors:  Clinton M Hasenour; D Emerson Ridley; Curtis C Hughey; Freyja D James; E Patrick Donahue; Jane Shearer; Benoit Viollet; Marc Foretz; David H Wasserman
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

Review 7.  Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases.

Authors:  Sandeep Rana; Elizabeth C Blowers; Amarnath Natarajan
Journal:  J Med Chem       Date:  2014-08-28       Impact factor: 7.446

8.  AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release.

Authors:  I P Salt; G Johnson; S J Ashcroft; D G Hardie
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

9.  AMP-activated protein kinase phosphorylates retinoblastoma protein to control mammalian brain development.

Authors:  Biplab Dasgupta; Jeffrey Milbrandt
Journal:  Dev Cell       Date:  2009-02       Impact factor: 12.270

10.  AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.

Authors:  Sandrine Marie; Benedicte Heron; Pierre Bitoun; Therese Timmerman; Georges Van Den Berghe; Marie-Francoise Vincent
Journal:  Am J Hum Genet       Date:  2004-04-26       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.